6th Annual Next Generation Sequencing Congress 2014

Over 400 delegates representing internationally renowned research & academic institutions, clinical research institutions, food & nutrition companies as well as leading pharmaceutical and biotech companies

Over 60 case studies and presentations focused on novel next generation sequencing platforms & technologies, the applications of NGS & key developments in cancer drug development and clinical diagnostics

Including 4 interactive streams:

  • NGS Technologies & Platforms
  • NGS Data Analysis Technologies & Platforms
  • NGS for Cancer Drug Development
  • NGS: Clinical Applications & Diagnostics

Co-located with the 2nd Annual Single Cell Analysis Congress

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global are proud to present the 6th Annual Next Generation Sequencing Congress taking place on 20th and 21st November 2014 at QEII Conference Centre, London, UK. Over the two days this prestigious congress will bring together over 400 senior level attendees from both academia and pharma to discuss the most crucial challenges in the next generation sequencing field.

The global NGS market is estimated to be worth $2.7 billion by 2017, double the value recorded in 2012. The tremendous advances in next generation sequencing technologies and platforms are opening fascinating opportunities in life science research. Novel discoveries identifying genetic mutations and genomic alterations have allowed for new opportunities in health and disease research.

Over the two days the Next Generation Sequencing Congress will cover presentations on the latest technologies and platforms including whole genome sequencing, ion torrent, nanopore technologies and third generation sequencing. Presentations will also include the use of NGS in human disease, microbiology and nutrition. In the NGS Data stream hear from leading academics discussing novel data analysis technologies and platforms. Topics will include: data analysis tools for integrating technologies and ’omics data sets, comparison of NGS platforms and metagenomics data analysis challenges.

This year we are delighted to introduce the co-located ‘NGS in Cancer Drug Development & Diagnostics Congress’ focussing on the latest tools for cancer drug development, NGS in personalised oncology, NGS for clinical applications, diagnostics and biomarkers.

The event is part of the highly successful Oxford Global Next Generation Sequencing Series. For more information on other events in the series, please see below:


Next Generation Sequencing Sponsors 2014:

51483-copytestimonials_26927

Media Partners

biotech-logo-200BioConferenceLivebenthamscienceebookmnt_logo_whitepharmavision_logobio-equip_logopharmaphorum-logo-250genlogotop_logobiosave-logogigasciencePharma Tech focusselectscience200csbj-logoallseqlogo-copybentham-scienceTechNet Communities(com)textlab-bulletin-logonew200rna-seq-blog-logoscaledapbnlabrootbpi-mp-logo_200bioportfolio-logobio-itworld_rgb200